Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Bruceine A 25514-31-2 1mg
SDP

Catalog No. 5000090737
Encompass_Preferred

Bruceine A (CAS 25514-31-2) is a natural quassinoid compound demonstrating inhibitory activity against intraerythrocytic Babesia species It is designed to suppress the proliferation of Babesia parasites thereby disrupting the parasitic lifecycle in host erythrocytes Bruceine A exerts its antiparasitic activity by inhibiting Babesia gibsoni growth In in vitro canine erythrocyte cultures Bruceine A demonstrates potent inhibition with an IC50 of approximately 7 7 nM and achieves parasite elimination at concentrations as low as 25 nM within 24 hours Based on these pharmacological properties Bruceine A holds research potential in exploring therapeutic approaches for canine babesiosis

Catalog No. 50-000-90737 Supplier Apexbio Technology LLC Supplier No. B36161
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Bruceine A (CAS 25514-31-2) is a natural quassinoid compound demonstrating inhibitory activity against intraerythrocytic Babesia species It is designed to suppress the proliferation of Babesia parasites thereby disrupting the parasitic lifecycle in host erythrocytes Bruceine A exerts its antiparasitic activity by inhibiting Babesia gibsoni growth In in vitro canine erythrocyte cultures Bruceine A demonstrates potent inhibition with an IC50 of approximately 7 7 nM and achieves parasite elimination at concentrations as low as 25 nM within 24 hours Based on these pharmacological properties Bruceine A holds research potential in exploring therapeutic approaches for canine babesiosis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.